VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Significant Increase in Short Interest

by · The Cerbat Gem

VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 3,148,062 shares, a growth of 41.9% from the December 15th total of 2,218,941 shares. Currently, 27.4% of the shares of the company are short sold. Based on an average daily trading volume, of 455,352 shares, the short-interest ratio is presently 6.9 days. Based on an average daily trading volume, of 455,352 shares, the short-interest ratio is presently 6.9 days. Currently, 27.4% of the shares of the company are short sold.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. CWM LLC raised its holdings in shares of VanEck Pharmaceutical ETF by 167.9% during the 2nd quarter. CWM LLC now owns 375 shares of the company’s stock worth $33,000 after buying an additional 235 shares in the last quarter. IFP Advisors Inc grew its position in VanEck Pharmaceutical ETF by 53.7% in the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock valued at $40,000 after acquiring an additional 153 shares during the last quarter. Advisory Services Network LLC acquired a new position in VanEck Pharmaceutical ETF during the third quarter worth about $41,000. PNC Financial Services Group Inc. lifted its holdings in shares of VanEck Pharmaceutical ETF by 305.6% in the third quarter. PNC Financial Services Group Inc. now owns 1,014 shares of the company’s stock worth $92,000 after acquiring an additional 764 shares during the last quarter. Finally, Creative Financial Designs Inc. ADV boosted its stake in shares of VanEck Pharmaceutical ETF by 18.1% in the 2nd quarter. Creative Financial Designs Inc. ADV now owns 2,129 shares of the company’s stock valued at $187,000 after purchasing an additional 327 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Up 0.3%

Shares of PPH traded up $0.28 during midday trading on Friday, reaching $105.32. 425,680 shares of the stock were exchanged, compared to its average volume of 406,816. The stock’s 50 day simple moving average is $101.94 and its 200 day simple moving average is $93.58. The company has a market cap of $1.22 billion, a P/E ratio of 20.21 and a beta of 0.54. VanEck Pharmaceutical ETF has a twelve month low of $77.67 and a twelve month high of $107.28.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 31st. Shareholders of record on Monday, December 29th were issued a $0.3106 dividend. The ex-dividend date of this dividend was Monday, December 29th. This represents a $1.24 dividend on an annualized basis and a yield of 1.2%.

VanEck Pharmaceutical ETF Company Profile

(Get Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Featured Stories